FDA grants priority review to cobimetinib combined with Zelboraf for advanced melanoma...
https://t.co/MVxzQWUpWy
— Domanique Culpepper (@DomCulpepper) February 21, 2015
from Twitter http://ift.tt/11Cavy0
February 20, 2015 at 08:14PM
via IFTTT
FDA grants priority review to cobimetinib combined with Zelboraf for advanced melanoma...
https://t.co/MVxzQWUpWy
— Domanique Culpepper (@DomCulpepper) February 21, 2015
No comments:
Post a Comment